Variation in BRCA1 cancer risks by mutation position

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 4, 2002, Pages 329-336

  Thompson, Deborah ^a   Easton, Douglas ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER RISK; CONTROLLED STUDY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT;

AGED; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; ODDS RATIO; OVARIAN NEOPLASMS; PHENOTYPE; RISK ASSESSMENT;

EID: 0036123926     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Linkage of early-onset familial breast cancer to chromosome 17q21
2. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
3. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a large population based series of breast cancer cases
4. Risk models for familial ovarian and breast cancer
5. Risks of cancer in BRCA1-mutation carriers
6. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
7. Growth retardation and tumour inhibition by BRCA1
8. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study
9. Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
10. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers
11. Programs for pedigree analysis: MENDEL, FISHER and dGENE
12. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families
13. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening
14. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer
15. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
16. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
17. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
18. Variation in risks of breast an ovarian cancer associated with different germline mutations of the BRCA2 gene
19. Internal repeats in the BRCA2 protein sequence
20. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene BRCA2
21. Clues to the function of the tumour susceptibility gene BRCA2
22. Association of BRCA1 with RAD51 in mitotic and meiotic cells
23. Molecular modeling of the amino-terminal zinc ring domain of BRCA1
24. Identification of a RING protein that can interact in vivo with the BRCA1 gene product
25. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
26. Mouse BRCA1: Localization, sequence analysis and identification of evolutionarily conserved domains
27. Murine BRCA1: Sequence and significance for human missense mutations
28. Human, canine and murine BRCA1 genes: Sequence comparison among species
29. BRCA1 protein products ... Functional motifs
30. Founder BRCA1/2 mutations among male patients with breast cancer in Israel
31. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q
32. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
33. High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history
34. King BRCA2 and the genetics of breast and ovarian cancer